BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fisher RA. Living donor liver transplantation: eliminating the wait for death in end-stage liver disease? Nat Rev Gastroenterol Hepatol. 2017;14:373-382. [PMID: 28196987 DOI: 10.1038/nrgastro.2017.2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Hendrickse A, Ko J, Sakai T. The care of donors and recipients in adult living donor liver transplantation. BJA Education 2022. [DOI: 10.1016/j.bjae.2022.06.004] [Reference Citation Analysis]
2 Bhatti ABH, Naqvi W, Ali N, Khan NY, Zia HH, Faiz BY, Ilyas A, Rana A, Khan NA. Textbook outcome among voluntary donors undergoing major living donor hepatectomy. Langenbecks Arch Surg 2022. [PMID: 35670859 DOI: 10.1007/s00423-022-02578-6] [Reference Citation Analysis]
3 Lee EK, Bang YJ, Kwon J, Park J, Ahn JH, Ko JS, Gwak MS, Kim GS. Change of Anesthetic Management From Open to Laparoscopic Living Donor Right Hepatectomy After Learning Curve. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2021.11.027] [Reference Citation Analysis]
4 Choi JY, Kim JH, Kim JM, Kim HJ, Ahn HS, Joh JW. Outcomes of living liver donors are worse than those of matched healthy controls. J Hepatol 2021:S0168-8278(21)02179-6. [PMID: 34785324 DOI: 10.1016/j.jhep.2021.10.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Zuckerman J, Gorgen A, Acuna SA, Abreu P, Goldaracena N, Galvin Z, Cattral MS, Ghanekar A, McGilvray ID, Lilly LB, Selzner N, Grant DR, Sapisochin G. Outcomes of Highly Selected Live Donors With a Future Liver Remnant Less Than or Equal to 30%: A Matched Cohort Study. Transplantation 2021;105:2397-403. [PMID: 33239541 DOI: 10.1097/TP.0000000000003559] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Oh SH, Jeong IS, Kim DY, Namgoong JM, Jhang WK, Park SJ, Jung DH, Moon DB, Song GW, Park GC, Ha TY, Ahn CS, Kim KH, Hwang S, Lee SG, Kim KM. Recent Improvement in Survival Outcomes and Reappraisal of Prognostic Factors in Pediatric Living Donor Liver Transplantation. Liver Transpl 2021. [PMID: 34536963 DOI: 10.1002/lt.26308] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Lai Q, Sapisochin G, Gorgen A, Vitale A, Halazun KJ, Iesari S, Schaefer B, Bhangui P, Mennini G, Wong TCL, Uemoto S, Lin CC, Mittler J, Ikegami T, Yang Z, Frigo AC, Zheng SS, Soejima Y, Hoppe-Lotichius M, Chen CL, Kaido T, Lo CM, Rossi M, Soin AS, Finkenstedt A, Emond JC, Cillo U, Lerut JP. Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant. JAMA Surg 2021;156:e213112. [PMID: 34259797 DOI: 10.1001/jamasurg.2021.3112] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
8 Zhang X, Tang L, Yi Q. Engineering the Vasculature of Stem-Cell-Derived Liver Organoids. Biomolecules 2021;11:966. [PMID: 34208902 DOI: 10.3390/biom11070966] [Reference Citation Analysis]
9 Bagheri Lankarani K, Honarvar B, Rouhezamin MR, Raeisi Shahraki H, Seifi V, Geramizadeh B, Salahi H, Nikeghbalian S, Shamsaeefar A, Keshani P, Malekhosseini SA. Mortality and Its Determinants in Adult Patients with End-stage Liver Disease on Waiting List for Liver Transplantation: A Preliminary Report on Baseline Data. Shiraz E-Med J 2021;22. [DOI: 10.5812/semj.110254] [Reference Citation Analysis]
10 Yoshiya S, Harada N, Tomiyama T, Takeishi K, Toshima T, Iguchi T, Itoh S, Ninomiya M, Yoshizumi T, Mori M. The Significant Prognostic Factors in Prolonged Intensive/High Care Unit Stay After Living Donor Liver Transplantation. Transplant Proc 2021;53:1630-8. [PMID: 33934913 DOI: 10.1016/j.transproceed.2021.02.020] [Reference Citation Analysis]
11 Marubashi S, Nagano H. Laparoscopic living-donor hepatectomy: Review of its current status. Ann Gastroenterol Surg 2021;5:484-93. [PMID: 34337297 DOI: 10.1002/ags3.12450] [Reference Citation Analysis]
12 Yang H, Sun L, Pang Y, Hu D, Xu H, Mao S, Peng W, Wang Y, Xu Y, Zheng YC, Du S, Zhao H, Chi T, Lu X, Sang X, Zhong S, Wang X, Zhang H, Huang P, Sun W, Mao Y. Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure. Gut 2021;70:567-74. [PMID: 32434830 DOI: 10.1136/gutjnl-2019-319960] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 41.0] [Reference Citation Analysis]
13 Xu X, Zhu YF, Lv T, Zheng JL, Li YK, Zhang BH, Jiang L, Yang JY. Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China. Medicine (Baltimore) 2020;99:e23584. [PMID: 33371088 DOI: 10.1097/MD.0000000000023584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Li T, Lv Y, Sun R, Yang YG, Hu Z, Lv G. Incompatibility between recipient CD47 and donor SIRPα is not a key risk factor for thrombocytopenia or anemia following rat liver xenotransplantation in mice. Xenotransplantation 2021;28:e12657. [PMID: 33111471 DOI: 10.1111/xen.12657] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Emamaullee J, Tenorio L, Khan S, Butler C, Kim S, Tucker‐seeley R, Kwon Y, Shapiro J, Saigal S, Sher L, Genyk Y. Living donor financial assistance programs in liver transplantation: The global perspective. Clin Transplant 2020;34. [DOI: 10.1111/ctr.14073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Raza MH, Jackson WE, Dell A, Ding L, Shapiro J, Pomfret EA, Genyk Y, Sher L, Emamaullee J. Health-related quality of life after anonymous nondirected living liver donation: A multicenter collaboration. Am J Transplant 2021;21:1056-67. [PMID: 32741102 DOI: 10.1111/ajt.16229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Kirchner VA, Goldaracena N, Sapisochin G, Alejandro RH, Shah SA. Current status of liver transplantation in North America. Int J Surg 2020;82S:9-13. [PMID: 32473238 DOI: 10.1016/j.ijsu.2020.05.059] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Peruhova M, Georgieva V, Yurukova N, Sekulovska M, Panayotova G, Mihova A, Terzieva V, Velikova TV. ABO-nonidentical liver transplantation from a deceased donor and clinical outcomes following antibody rebound: A case report. World J Transplant 2020; 10(5): 138-146 [PMID: 32864359 DOI: 10.5500/wjt.v10.i5.138] [Reference Citation Analysis]
19 Bernts LHP, Neijenhuis MK, Edwards ME, Sloan JA, Fischer J, Smoot RL, Nagorney DM, Drenth JPH, Hogan MC. Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease. Surgery 2020;168:25-32. [PMID: 32402542 DOI: 10.1016/j.surg.2020.02.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Heinemann M, Adam R, Berenguer M, Mirza D, Malek-Hosseini SA, O'Grady JG, Lodge P, Pratschke J, Boudjema K, Paul A, Zieniewicz K, Fronek J, Weiss KH, Karam V, Duvoux C, Lohse A, Schramm C; all the other contributing centers (www.eltr.org) and the European Liver and Intestine Transplant Association (ELITA). Longterm Survival After Liver Transplantation for Autoimmune Hepatitis: Results From the European Liver Transplant Registry. Liver Transpl 2020;26:866-77. [PMID: 32112516 DOI: 10.1002/lt.25739] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
21 Raza MH, Kim MH, Ding L, Fong TL, Romero C, Genyk Y, Sher L, Emamaullee J. Long-Term Financial, Psychosocial, and Overall Health-Related Quality of Life After Living Liver Donation. J Surg Res 2020;253:41-52. [PMID: 32320896 DOI: 10.1016/j.jss.2020.03.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Raza MH, Aziz H, Kaur N, Lo M, Sher L, Genyk Y, Emamaullee J. Global experience and perspective on anonymous nondirected live donation in living donor liver transplantation. Clin Transplant 2020;34:e13836. [PMID: 32154620 DOI: 10.1111/ctr.13836] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
23 Goldaracena N, Barbas AS. Living donor liver transplantation. Curr Opin Organ Transplant. 2019;24:131-137. [PMID: 30694993 DOI: 10.1097/mot.0000000000000610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Glas A. Join the Lone Kidney Club: incentivising live organ donation. J Med Ethics 2021;47:618-22. [PMID: 32060210 DOI: 10.1136/medethics-2019-105999] [Reference Citation Analysis]
25 Feng Y, Han Z, Feng Z, Wang B, Cheng H, Yang L, Li Y, Gu B, Li X, Li Y, Li Y, Wang C, Chen H. Approaching treatment for immunological rejection of living-donor liver transplantation in rats. BMC Gastroenterol 2020;20:7. [PMID: 31931737 DOI: 10.1186/s12876-019-1130-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Fisher RA. Anonymous live liver donor: the Good Samaritan Stranger. Nat Rev Gastroenterol Hepatol 2019;16:650-1. [PMID: 31501587 DOI: 10.1038/s41575-019-0207-x] [Reference Citation Analysis]
27 Cahalane AM, Mojtahed A, Sahani DV, Elias N, Kambadakone AR. Pre-hepatic and pre-pancreatic transplant donor evaluation. Cardiovasc Diagn Ther 2019;9:S97-S115. [PMID: 31559157 DOI: 10.21037/cdt.2018.09.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Goldaracena N, Jung J, Aravinthan AD, Abbey SE, Krause S, Pritlove C, Lynch J, Wright L, Selzner N, Stunguris J, Greig P, Ghanekar A, McGilvray I, Sapisochin G, Ng VL, Levy G, Cattral M, Grant D. Donor outcomes in anonymous live liver donation. J Hepatol 2019;71:951-9. [PMID: 31279899 DOI: 10.1016/j.jhep.2019.06.027] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
29 Yadav DK, Hua YF, Bai X, Lou J, Que R, Gao S, Zhang Y, Wang J, Xie Q, Edoo MIA, Chutturghoon VK, Liang T. ABO-Incompatible Adult Living Donor Liver Transplantation in the Era of Rituximab: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2019;2019:8589402. [PMID: 31285743 DOI: 10.1155/2019/8589402] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
30 Zhang QY, Zhang QF, Zhang DZ. The Impact of Steatosis on the Outcome of Liver Transplantation: A Meta-Analysis. Biomed Res Int 2019;2019:3962785. [PMID: 31218224 DOI: 10.1155/2019/3962785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tsai HI, Lo CJ, Zheng CW, Lee CW, Lee WC, Lin JR, Shiao MS, Cheng ML, Yu HP. A Lipidomics Study Reveals Lipid Signatures Associated with Early Allograft Dysfunction in Living Donor Liver Transplantation. J Clin Med 2018;8:E30. [PMID: 30597989 DOI: 10.3390/jcm8010030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
32 Lan X, Zhang H, Li HY, Chen KF, Liu F, Wei YG, Li B. Feasibility of using marginal liver grafts in living donor liver transplantation. World J Gastroenterol 2018; 24(23): 2441-2456 [PMID: 29930466 DOI: 10.3748/wjg.v24.i23.2441] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
33 Makhlouf NA, Abdel-Monem SA, Farghaly AM, Helmy A. Attitude of Upper Egypt Health-Care Professionals Toward Living Liver Donation and Transplantation. Prog Transplant 2018;28:256-62. [PMID: 29916297 DOI: 10.1177/1526924818781565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Li J, Xing F, Chen F, He L, So KF, Liu Y, Xiao J. Functional 3D Human Liver Bud Assembled from MSC-Derived Multiple Liver Cell Lineages. Cell Transplant 2019;28:510-21. [PMID: 29895168 DOI: 10.1177/0963689718780332] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
35 Wen PH, Lu CL, Strong C, Lin YJ, Chen YL, Li CY, Tsai CC. Demographic and Urbanization Disparities of Liver Transplantation in Taiwan. Int J Environ Res Public Health 2018;15:E177. [PMID: 29360736 DOI: 10.3390/ijerph15020177] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]